Deal round up: US biotechnology maintains momentum

US biotechnology companies maintained the momentum for investment they saw last week, with new investment opportunities arising in a number of areas as the country attempts to diversify its renewables mix.

Powered by WPeMatico

This entry was posted in Energy. Bookmark the permalink.

Comments are closed.